The mechanism of amobarbital action during the intracarotid amobarbital procedure is poorly understood.
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Introduction:
The intracarotid amobarbital procedure (IAP) is used to provide prognostic information prior to epilepsy surgery, but it may also provide interesting insights into brain function. Milner and Wada, the developers of the procedure, described the function of the amobarbital as to, "temporarily inactivate," the anterior circulation of one hemisphere of the brain [1, 2] , but this mechanism does not explain some observations during the procedure. For example, EEG changes are frequently bilateral, rather than merely ipsilateral to the injection side on scalp EEG [3, 4] and intracranial EEG [5] . Although this could possibly be attributed to crossing of the drug to the contralateral hemisphere via the circle of Willis, nuclear medicine studies show that the drug passes to the other hemisphere a very small proportion of the time [6] . This suggests that the unilateral inactivation model for amobarbital action cannot adequately explain the unilateral deficits observed during the procedure. Other authors have speculated that amobarbital may function in this setting by, "deafferentation," from cortical and subcortical structures [6] ; however, this description does not clarify the physiologic mechanism for this deafferentation.
To begin to clarify the mechanism of amobarbital in producing unilateral deficits, we report a case of a patient who underwent IAP while implanted with bilateral stereo-EEG. The activity during the procedure was evaluated using measures of nested and synchronous oscillations. Measures of nested oscillations such as phase amplitude coupling and synchrony such as cluster-phase group synchrony were selected because existing evidence indicates their importance in cognitive function [7, 8] , and dysfunction of these measures has been implicated in poor cognitive performance [9] . For example, pathological PAC has been recorded in Parkinson's disease [10] .
Materials and Methods:
2.1 Consent: The study was conducted according to the principles of the Declaration of Helsinki, and the consent documentation and procedure were approved by the Mount Sinai Hospital Institutional Review Board.
Patient:
The patient at the time of surgery was a 41-year-old right-handed male with medically refractory epilepsy since age 17. The semiology of his events was a feeling of coldness and nausea A C C E P T E D M A N U S C R I P T followed by bilateral automatisms of the hands, associated with amnesia for the event. These would proceed to a generalized convulsion very infrequently. He had continued to seize on lamotrigine, levetiracetam, and oxcarbazepine, and had failed treatment with zonisamide, lacosamide, and carbamazepine. Interictal EEG showed bilateral frontotemporal sharp waves, and multiple left frontotemporal seizures were captured in the epilepsy monitoring unit. His MRI was normal. Because of the presence of bilateral interictal discharges and a nonlesional MRI, it was decided that the patient should undergo bilateral stereo-EEG. The IAP was performed while the patient was implanted with bilateral stereo-EEG due to unreliable follow up after multiple attempts pre-implanation.
Data Collection and Pre-Analysis:
Electrophysiological data was collected for all subjects using a Natus Quantum amplifier (Natus Medical Incorporated; Pleasanton, CA). The sampling rate was 1024 Hz.
All pre-analysis and analysis was performed with MATLAB (Mathworks, Natick, MA) using the FieldTrip software library [11] . Recordings were referenced to the average of all electrodes. Each trace was locally detrended. AC noise was removed using a 60 Hz notch filter.
Electrode Localization:
Localization of electrodes was performed using pre-operative MRIs and postoperative CTs. Coregistration of MRI and CT was performed using iELVIS [12] and the location of each electrode was selected on the post-operative CT. A parcellated image of the patient's cortical surface was generated using FreeSurfer from the T1 series of the pre-operative MRI. Cortical parcellation is by the DKT40 Atlas [13] .
Analysis:
The data from each electrode was divided into 10 second windows with 5 second step-size.
Spectral power was calculated using a complex Morlet wavelet transformation (width = 7). Spectral power was calculated for all electrodes from between 1 to 150 Hz, calculated at 1 Hz increments. Clusterphase group synchronya global variable representing the phase locking of multiple signals at a given frequency --was calculated between all the electrodes in each frontal lobe between 1 to 150 Hz, calculated at 1 Hz increments [14] . Phase amplitude couplinga measure of the tendency of high frequency oscillations to occur at particular phases of low frequency oscillations --was calculated for 1 to
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20 Hz in 1 Hz increments (phase frequency) and 30 to 150 Hz in 10 Hz increments (amplitude frequency) [15] .
Results:
3.1 IAP Results: Wada testing was performed during implantation with first left, then right intracarotid injection of 100 mg of amobarbital. After the left sided injection, the patient was aphasic and plegic on the right. The patient was plegic on the left after the right sided injection. Left sided memory function was 3 out of 10 exemplars. Right sided memory function was 4 out of 8 exemplars. Figure   1 , Supplementary Table 1 ). Because the borders of the anterior circulation in the temporal lobe could not be clearly determined, the analysis divided electrodes that were in the frontal lobe from those in the temporal lobe. Of these, 23 electrodes were excluded because they were located more than 5 mm from a gray matter structure.
Electrode Localization: 98 electrodes were placed bilaterally into this patient (Supplementary

Spectral Power:
The Z-score of the average spectral power for the 1-150 Hz frequencies for electrodes from each frontal lobe are depicted in Figure 1A . At the time of both the left and the rightsided injection there is a visible increase in delta (1-3 Hz) power and high gamma (80-150 Hz) power bilaterally. The Z-scored spectral power for these bands is depicted in Figure 1B . A similar analysis for all of the electrodes in the right and left temporal lobe produced similar results ( Supplementary Figure 2A and 2B). Analysis of the spectral power in the beta (15-29 Hz) and low gamma (30-79 Hz) show bilateral increases, but we less accurate at lateralizing the side of activity ( Supplementary Figure 3 ).
Phase Amplitude Coupling:
Nested oscillations are speculated to support brain functions and are correlated with performance in tasks such as memory [7] . A measure of nested oscillations is the phaseamplitude coupling, the tendency of the peaks of high frequency oscillations to cluster at a phase of a lower frequency oscillation. This measure was calculated for 1-20 Hz (phase frequency) and 30-150 (amplitude frequency) for all electrodes in the right and left frontal lobes. For the 2-3 Hz (phase frequency) and 30-70 Hz (amplitude frequency) there is an increase in PAC ipsilateral, but not
contralateral to the injection ( Figure 1C) . A similar analysis for all of the electrodes in the right and left temporal lobe produced similar results (Supplementary Figure 2C ).
Synchrony:
Synchronous oscillations between brain regions are hypothesized to support brain function by organizing different units into functional networks [8] . A global measure of synchrony is cluster-phase group synchrony, the tendency of a group of oscillators to align to the same phase [15] . This measure was calculated between 1 to 150 Hz, calculated at 1 Hz increments for all the electrodes in the left and right frontal lobe. Figure 1D shows a reduction in the Z-scored cluster-group synchrony in the 4-30 Hz ipsilateral to the injection and an increase in the Z-scored cluster group synchrony in the low and high gamma bands ipsilateral to the injection. These changes are present to a lesser degree contralateral to the injection. A similar analysis for all of the electrodes in the right and left temporal lobe produced similar results (Supplementary Figure 2D ). Thus, after intracarotid amobarbital, lower-frequency oscillators in the injected hemisphere tend to fall out of phase, whereas higher-frequency oscillators tend to increase phase synchrony. This pattern of synchrony closely resembles the pattern observed in poor memory performance in behavioral testing of patients implanted with intracranial EEG [9] .
Discussion
These results detail the electrophysiologic changes observed in a single patient who underwent IAP while implanted with bilateral stereo-EEG. As has been observed in prior scalp [3, 4] and intracranial studies [5] , there was a significant bilateral increase in delta power both ipsilateral and contralateral to the injection. Although the delta power increase was more prominent ipsilateral to the injection, the relative asymmetry in delta power may not fully explain the unilateral deficits in the patient after injection. By contrast, changes in phase amplitude coupling for 2-3 Hz (phase frequency) and 30-70 (amplitude frequency) and cluster-phase group synchrony in the 4-30 Hz and 30-150 Hz bands appear in this case to more accurately lateralized the deficits observed in this patient.
The additional observation that low and high gamma power increase bilaterally is incongruous with the purported action of amobarbital in decreasing neuronal firing. It is possible that cognitive load performing the task or patient movement account for these increases. Alternatively, early studies in a dog
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A C C E P T E D M A N U S C R I P T model of amobarbital showed increased bursting activity after administration [16] . It is possible that this bursting activity is being recorded as an increase in spectral power in the gamma range.
That synchronous and nested oscillations are may be better at lateralizing the side of injection draws into question the hypothesis that amobarbital functions solely by, "inactivating," the injected region. Rather, these suggest that an additional mechanism of amobarbital action may be by the disruption of the temporal structure of oscillations of the local field potential, which removes the information encoded in nested oscillations and desynchronizes previously synchronous nodes in existing neural networks. Pathological increases in phase amplitude coupling have been noted in Parkinson's disease [10] . Similarly, a recent analysis of patients performing memory tasks while implanted with intracranial EEG showed that theta band synchronization and gamma desynchronization correlated with performance [9] . Our finding that the amobarbital injection causes a similar desynchronization in 4-30 Hz and synchronization in the gamma band demonstrates that the drug causes a brain state associated with poor memory performance suggests that these changes in synchrony may account for the drugs effect as an amnestic agent.Further, these quantitative observations on the intracranial signal have implications to interpretation of the scalp EEG during the procedure. It may not be possible to determine the effectiveness of the drug on the basis of qualitative evaluation of scalp EEG.
These results should be interpreted with caution as this is a single case. Other agents sometimes used in the procedure such as propofol or methohexital may have other mechanisms of action. However, if validated and repeated in a larger series, these results have broad implications for our understanding of brain function. Synchronous and nested oscillations are hypothesized to organize neural networks, yet evidence to support this hypothesis is almost exclusively correlative [17] . The results of this case study add evidence to the hypothesis that timing of oscillatory activity is necessary for brain function.
Conclusion:
In this case, we show that measures of nested oscillations and synchrony may lateralize the deficits better than measures of spectral power. These results imply a possible alternative mechanism for
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amobarbital action and supports the hypothesis that nested and synchronous oscillations are necessary for brain function. The authors have no conflicts of interest to declare.
Highlights:
• Intracranial activity shows bilateral increases in delta and gamma activity during the IAP.
• Phase amplitude coupling, a measure of nested oscillations, increases in the 2-3 Hz (phase frequency) and 30-70 Hz (amplitude frequency) band only ipsilateral to the injection.
• 4-30 Hz cluster-phase group synchronya global measure of phase lockingdeclines and gamma cluster-phase group synchrony increases only ipsilateral to the injection.
• The mechanism of action for amobarbital may be by altering the temporal organization of activity, rather than simply inactivation of the injected hemisphere. 
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